Lilyana Amezcua
Division Chief, Multiple Sclerosis & Neuroimmunology · University of Southern California/Los Angeles General Medical Center
Credentials: · · · · ·
History
PresentMultiple Sclerosis & Neuroimmunology Division · University of Southern California/Los Angeles General Medical Center
- 2007–2008
USC Care Medical Group
Research
Blood-brain barrier breakdown in the aging human hippocampus
Neuron · 2015 · 1,685 citations
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
Review · The Lancet Neurology · 2025 · 326 citations
Review · JAMA Neurology · 2021 · First of 5 authors · 145 citations
16 papers
10 papers · 9 as a resident
- AO
8 papers
6 papers
6 papers
6 papers
5 papers
5 papers
Grants
- 2026–2030
Improving Disease-Modifying Therapy Uptake Among Patients with Multiple Sclerosis
National Institute of Neurological Disorders and Stroke · R01
PI · $663K · University of Kentucky
- 2025–2027
Capacity Building for Timely Diagnosis of Multiple Sclerosis and Prevention of Disability
Fogarty International Center · RF1
Contact PI · $375.3K · University of Southern California
- 2021–2027
Immunology of Advancing Disease Among Minorities with Multiple Sclerosis
National Institute of Neurological Disorders and Stroke · R01
PI · $2.7M · Ut Southwestern Medical Center
Clinical trials
- 2012–2018
Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS
Principal investigator · Completed
University of Southern California